Umifenovir serup inhaler: Umifenovir Drug for Covid: CDRI claims Umifenovir can eliminate viral load in five days

Umifenovir serup inhaler: Umifenovir Drug for Covid: CDRI claims Umifenovir can eliminate viral load in five days

New Delhi
Covid Drug Umifenovir: Scientists of the Central Drug Research Institute (CDRI) have discovered the country’s first antiviral drug Umifenovir to control the corona. CDRI claims that after successful Phase III trials on 132 corona patients so far, Umifenovir is effective in treating patients with asymptomatic and mild symptoms of corona.

According to CDRI scientists, the antiviral drug umifenovir is also expected to work in the delta plus variant of Covid, as it has also been found to be effective in corona patients of the delta variant. Scientists from CDRI claim that it completely eliminates the viral load in five days.

Also read: MSIL: Why Stock Expert Nischal Maheshwari Isn’t Buying Shares Of Country’s Largest Carmaker

Umifenovir used as a trial
CDRI director Tapas Kundu said that during the corona epidemic, umifenovir was used as a trial drug at the behest of 16 members of CDRI. After a three-phase trial on corona patients, umifenovir has been found to be effective in the treatment of patients with asymptomatic and mild symptoms. In such corona patients, 800 mg dose of umifenovir has to be taken twice a day for five days to almost eliminate the effect of the virus.

effective in fast recovery
Rapid recovery has been observed in corona patients due to the effect of Umifenovir. The umifenovir trial involved patients aged 18-75 years. The technology of making the medicine has been given to the Medigest M/s of Goa. Umifenovir may soon be launched in the form of tablets and syrups. The price of umifenovir will be kept within the reach of patients. He told that for the last 20 years, this drug has been used in Russia, China and other countries in the treatment of diseases like influenza and pneumonia.

See also  HDFC Bank Q1 net profit up 14 per cent at Rs 7,922 crore - hdfc bank q1 net profit up 14 per cent at Rs 7922 crore

safe for kids too
CDRI’s Chief Scientist R Ravi Shankar said, “Umifenovir, which is used in the treatment of corona, is safe for pregnant women and children as well.” Umifenovir effectively destroys the cell culture of SARS COVID-19. It prevents the entry of corona virus into human cells. The cost of a five-day drug of Umifenovir comes to around Rs 600. The Drug Controller General of India (DCGI) has evaluated the clinical trial reports and asked to continue the study on more mild symptomatic patients for emergency use approval.

Also read: Only 10 percent of the rich of the country have more than half the wealth-money

Warren Buffett’s indicator created an atmosphere of fear in the stock market

#Umifenovir #serup #inhaler #Umifenovir #Drug #Covid #CDRI #claims #Umifenovir #eliminate #viral #load #days

Leave a Comment

close
%d bloggers like this: